Aspiration to check whether the needle is in a blood vessel is not necessary (PHE, 2013)
Mounjaro (tirzepatide) EPAR Assessment Report
Methods: Thirty-two patients with T2D were evaluated at baseline (T0) and after three (T3) and six (T6) months of therapy with oral semaglutide
The Bottom Line Survodutide and tirzepatide both target the GLP-1/GIP dual-agonist pathway, but tirzepatide carries the more extensive published trial record, while survodutide represents an earlier-stage compound with a smaller but growing dataset
When Supplementation May Be Appropriate During GLP-1 Treatment Electrolyte support, vitamin B12, and iron supplementation may be medically necessary during GLP-1 therapy because reduced food intake can lead to micronutrient gaps
(Osaka, Japan), Pfizer Japan Inc